SE503222C2 - Farmaceutiska beredningar med reglerad frisättning av isradipin eller darodipin - Google Patents

Farmaceutiska beredningar med reglerad frisättning av isradipin eller darodipin

Info

Publication number
SE503222C2
SE503222C2 SE8604112A SE8604112A SE503222C2 SE 503222 C2 SE503222 C2 SE 503222C2 SE 8604112 A SE8604112 A SE 8604112A SE 8604112 A SE8604112 A SE 8604112A SE 503222 C2 SE503222 C2 SE 503222C2
Authority
SE
Sweden
Prior art keywords
isradipine
release
pindolol
darodipine
capsule
Prior art date
Application number
SE8604112A
Other languages
English (en)
Swedish (sv)
Other versions
SE8604112D0 (sv
SE8604112L (sv
Inventor
Othmar Zueger
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB858524135A external-priority patent/GB8524135D0/en
Priority claimed from GB858524653A external-priority patent/GB8524653D0/en
Priority claimed from GB858531419A external-priority patent/GB8531419D0/en
Priority claimed from GB868603097A external-priority patent/GB8603097D0/en
Priority claimed from GB868605037A external-priority patent/GB8605037D0/en
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of SE8604112D0 publication Critical patent/SE8604112D0/xx
Publication of SE8604112L publication Critical patent/SE8604112L/
Publication of SE503222C2 publication Critical patent/SE503222C2/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/485—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
SE8604112A 1985-10-01 1986-09-29 Farmaceutiska beredningar med reglerad frisättning av isradipin eller darodipin SE503222C2 (sv)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB858524135A GB8524135D0 (en) 1985-10-01 1985-10-01 Darodipine compositions
GB858524653A GB8524653D0 (en) 1985-10-07 1985-10-07 Pharmaceutical formulations
GB858531419A GB8531419D0 (en) 1985-12-20 1985-12-20 Pindolol compositions
GB868603097A GB8603097D0 (en) 1986-02-07 1986-02-07 Pharmaceutical formulations
GB868605037A GB8605037D0 (en) 1986-02-28 1986-02-28 Oral pharmaceutical compositions

Publications (3)

Publication Number Publication Date
SE8604112D0 SE8604112D0 (sv) 1986-09-29
SE8604112L SE8604112L (sv) 1987-04-02
SE503222C2 true SE503222C2 (sv) 1996-04-22

Family

ID=27516617

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8604112A SE503222C2 (sv) 1985-10-01 1986-09-29 Farmaceutiska beredningar med reglerad frisättning av isradipin eller darodipin

Country Status (20)

Country Link
KR (1) KR920008817B1 (de)
AT (1) AT402257B (de)
BE (1) BE905516A (de)
CA (1) CA1298784C (de)
CH (1) CH669524A5 (de)
DE (1) DE3632201C2 (de)
DK (1) DK170016B1 (de)
ES (1) ES2002508A6 (de)
FR (1) FR2589732B1 (de)
GR (1) GR862457B (de)
HK (1) HK392A (de)
HU (1) HU197201B (de)
IE (1) IE59589B1 (de)
IL (1) IL80182A (de)
LU (1) LU86615A1 (de)
NL (1) NL194822C (de)
NZ (1) NZ217732A (de)
PT (1) PT83456B (de)
SE (1) SE503222C2 (de)
SG (1) SG103391G (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6440457B1 (en) 1993-05-27 2002-08-27 Alza Corporation Method of administering antidepressant dosage form
US6855729B2 (en) * 2001-02-20 2005-02-15 Timothy G. Dinan Treatment of fibromyalgia and related fatigue syndromes using antagonists or partial agonists of 5HT1a receptors
TW200616681A (en) * 2004-10-05 2006-06-01 Recordati Ireland Ltd Lercanidipine capsules

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH630257A5 (en) * 1975-03-17 1982-06-15 Hoffmann La Roche Sustained release formulation
CH639659A5 (de) * 1978-12-18 1983-11-30 Sandoz Ag Neue 1,4-dihydropyridinderivate, deren herstellung und verwendung.
DD145004A3 (de) * 1978-09-25 1980-11-19 Reinhard Huettenrauch Verfahren zur herstellung fester a zneiformen
CA1146866A (en) * 1979-07-05 1983-05-24 Yamanouchi Pharmaceutical Co. Ltd. Process for the production of sustained release pharmaceutical composition of solid medical material
JPS6056122B2 (ja) * 1980-05-21 1985-12-09 塩野義製薬株式会社 徐放性製剤
GB2084017B (en) * 1980-09-18 1984-08-22 Sandoz Ltd Pharmaceutical compositions effective against coronary heat disease and hypertension
US4369172A (en) * 1981-12-18 1983-01-18 Forest Laboratories Inc. Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose
CA1208558A (en) * 1982-10-07 1986-07-29 Kazuo Kigasawa Soft buccal
GB2154874B (en) * 1984-02-29 1987-11-04 Sandoz Ltd Bromoscriptine compositions
JPS61501511A (ja) * 1984-03-21 1986-07-24 アメリカン・ホ−ム・プロダクツ・コ−ポレイション 徐放性医薬カプセル
JPS6124516A (ja) * 1984-07-12 1986-02-03 Fujisawa Pharmaceut Co Ltd 持続性錠剤

Also Published As

Publication number Publication date
FR2589732A1 (fr) 1987-05-15
PT83456A (en) 1986-10-01
AT402257B (de) 1997-03-25
PT83456B (pt) 1989-05-12
CA1298784C (en) 1992-04-14
SE8604112D0 (sv) 1986-09-29
HUT44701A (en) 1988-04-28
IE862565L (en) 1987-04-01
HU197201B (en) 1989-03-28
LU86615A1 (fr) 1987-04-02
CH669524A5 (de) 1989-03-31
DK464686A (da) 1987-04-02
KR870003777A (ko) 1987-05-04
DK464686D0 (da) 1986-09-29
IL80182A (en) 1991-01-31
ATA260486A (de) 1996-08-15
SE8604112L (sv) 1987-04-02
NL194822C (nl) 2003-04-03
IE59589B1 (en) 1994-03-09
KR920008817B1 (ko) 1992-10-09
DK170016B1 (da) 1995-05-01
DE3632201A1 (de) 1987-04-02
NL194822B (nl) 2002-12-02
SG103391G (en) 1992-01-17
DE3632201C2 (de) 1997-05-07
GR862457B (en) 1987-01-29
HK392A (en) 1992-01-10
ES2002508A6 (es) 1988-08-16
FR2589732B1 (fr) 1989-07-13
IL80182A0 (en) 1986-12-31
NZ217732A (en) 1990-07-26
BE905516A (fr) 1987-03-30
NL8602370A (nl) 1987-05-04

Similar Documents

Publication Publication Date Title
US5071642A (en) Dihydropyridine containing compositions
AU602677B2 (en) New pharmaceutical preparations with extended release
AU2008207703A1 (en) Sustained release ranolazine formulations
US5399360A (en) Pharmaceutical compositions
CA2030962C (en) Improvements relating to the administration of pharmaceutical agents
GB2154874A (en) Bromocriptine compositions
CN115518066A (zh) 一种用于治疗抗凝血的药物组合物及应用
GB2181053A (en) Controlled release formulation
SE503222C2 (sv) Farmaceutiska beredningar med reglerad frisättning av isradipin eller darodipin
Saseen et al. Postabsorption concentration peaks with brand‐name and generic verapamil: a double‐blind, crossover study in elderly hypertensive patients
ITMI970047A1 (it) Composizione farmaceutica antitubercolare e procedimento per la sua produzione
AU598751B2 (en) Pharmaceutical formulations with controlled release of the active substance
AU618599B2 (en) Controlled release bromocriptine formulations
JPS62149618A (ja) 活性物質放出制御医薬製剤
KR950007229B1 (ko) 케토티펜을 함유한 약학적 조성물
Zema et al. Serum drug concentrations in patients with ischemic heart disease after administration of a sustained release procainamide preparation
Campbell et al. Fenfluramhe plasma concentrations after administration of a sustained-release capsule formulation and rapid-release tablets
Mirando Serum Drug Concentrations in Patients with Ischemic Heart Disease After Administration of Sustained Release Procainamide Preparation
Zannad et al. CONVERSION FROM INTRAVENOUS TO ORAL SLOW‐RELEASE DISOPYRAMIDE IN ACUTE MYOCARDIAL INFARCTION

Legal Events

Date Code Title Description
NUG Patent has lapsed